Viewing Study NCT00238368


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-02-03 @ 12:29 PM
Study NCT ID: NCT00238368
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2005-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None contiguous stage II adult diffuse large cell lymphoma View
None noncontiguous stage II adult diffuse large cell lymphoma View
None stage I adult diffuse large cell lymphoma View
None stage III adult diffuse large cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None contiguous stage II grade 3 follicular lymphoma View
None noncontiguous stage II grade 3 follicular lymphoma View
None stage I grade 3 follicular lymphoma View
None stage III grade 3 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None anaplastic large cell lymphoma View
None stage I adult T-cell leukemia/lymphoma View
None stage II adult T-cell leukemia/lymphoma View
None stage III adult T-cell leukemia/lymphoma View
None stage IV adult T-cell leukemia/lymphoma View